Treace Announces First Surgical Case With The Hyperplatetm XM Dynamic Compression Locking Implant System

(MENAFN- GlobeNewsWire - Nasdaq) New portfolio addition to drive further penetration into incremental procedures throughout the foot and ankle; strengthens Treace's comprehensive suite of technologies for its growing customer base

PONTE VEDRA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the“Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its HyperPlateTM XM Dynamic Compression Locking Implant.

HyperPlateTM fixation technology further advances the SpeedPlate® implant platform by incorporating FastPitch® locking screws into the titanium compression implants to deliver rapid insertion and dynamic compression across the fusion site with enhanced multiplanar strength and stability. The HyperPlateTM XM Dynamic Compression Locking Implant has been engineered with a versatile anatomic design featuring an ultra-low profile implant with multiple sizes to accommodate a wide range of midfoot and hindfoot procedures including talonavicular, calcaneocuboid, naviculocuneiform and tarsometatarsal fusion applications in addition to Evans calcaneal osteotomies. The HyperPlateTM XM system is complemented with new single-use, sterile instruments, including the GreatReleaseXMTM Rapid Release Instrument, specifically designed to facilitate efficient release and joint preparation of these larger midfoot and hindfoot joints.

Paul Dayton, DPM, of the Foot & Ankle Center of Iowa (Des Moines, Iowa) and a member of Treace's Surgeon Advisory Board, performed the first case with the new HyperPlateTM XM implant. He commented,“Fusions of the larger joints of the midfoot and hindfoot can be challenging and have been associated with high non-union rates. The HyperPlateTM XM implant's combination of locking screws and dynamic compression provides a highly stable construct with an anatomic shape designed to promote fusion in these larger midfoot and hindfoot applications. My first case was a talonavicular (TN) joint fusion and I was impressed with the streamlined insertion, anatomic fit, and the stability of the implants. Additionally, achieving complete soft-tissue release of the TN joint was significantly more efficient with the use of the new GreatReleaseXMTM Rapid Release Instrument.”

“The launch of HyperPlateTM XM implants marks another important step in the continued expansion of our market-leading bunion and midfoot portfolio,” said John T. Treace, CEO and Chairman of Treace.“As we highlighted earlier this year, we remain focused on expanding our procedural reach broadly throughout the foot and ankle. HyperPlateTM XM implants are an example of that strategy in action, providing surgeons with another innovative solution that complements our existing technologies and supports the growing adoption of our expanding portfolio. We believe HyperPlateTM XM implants, together with our SuperBiteTM Compression Screws platform, strengthens our ability to participate in a larger addressable market, drive increased procedural utilization, and deepen customer engagement, while further advancing Treace as a comprehensive foot and ankle technology partner.

MENAFN18062026004107003653ID1111277330